Carboxymethyl chitosan/sodium alginate nano hydrogel as well as preparation method and application
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- OCEAN UNIV OF CHINA
- Publication Date
- 2019-12-31
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of biomaterials, in particular to a carboxymethyl chitosan / sodium alginate nano hydrogel. Background technique
[0002] Type 1 diabetes is generally thought to be related to the destruction of insulin-producing pancreatic beta cells, and the immediate need for exogenous insulin is also a hallmark of type 1 diabetes, which requires lifelong treatment. Insulin is still the main drug in the treatment of type 1 diabetes. Due to its nature as a protein drug, invasive parenteral treatment (ie, injection treatment) is still a widely used delivery method. Its effectiveness is limited by the patient's needle phobia, pain, skin swelling, allergic reactions, common infections, and the stress of living on long-term insulin therapy. Also, many patients still suffer from hypoglycemic episodes despite simpler and more effective blood glucose monitoring measures. The incidence of the above adverse reactions varies, and it...